Ligand validation:9G16

RET: RETINAL

RET is a Ligand Of Interest in 9G16 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9G16_RET_A_515	93%	50%	0.059	0.951	0.88	1.04	1	3	4	0	100%	1
7AVP_RET_A_319	100%	60%	0.035	0.984	0.67	0.87	-	-	3	0	100%	1
8RSO_RET_B_511	93%	48%	0.065	0.959	1.1	0.91	1	1	4	0	100%	1
8RSS_RET_A_515	88%	61%	0.054	0.928	0.73	0.75	-	1	3	0	100%	1
7AVN_RET_B_317	83%	8%	0.076	0.933	2.81	1.88	3	9	8	0	100%	1
5JSI_RET_A_323	82%	24%	0.077	0.93	1.49	1.61	3	7	6	0	100%	1
4OV0_RET_A_301	100%	8%	0.027	0.992	0.76	3.77	-	15	8	0	100%	1
9F9J_RET_A_317	100%	71%	0.026	0.991	0.7	0.44	1	-	5	0	100%	1
3UTY_RET_A_301	100%	5%	0.028	0.992	2.48	2.7	6	12	2	0	100%	1
7XJC_RET_A_301	100%	10%	0.028	0.992	1.93	2.43	2	14	2	0	100%	0.5
7XJD_RET_A_301	100%	10%	0.029	0.991	1.93	2.42	2	14	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.